Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • qdelfan qdelfan Aug 3, 2013 12:58 PM Flag

    Upcoming annual medical conferences where important clinical data realeases expected

    NACF (national Cf meeting) Oct. 19
    ACR (national rheumatology meeting) Oct 25
    AASLD (national hepatology meeting) Nov 1 through Nov 5

    Over the two weeks from Oct 19 through Nov 5 expect new data on the CF RA and hep C drugs in development from Vertex (if not released earlier), and well as announcements of partnership/licensing deals for ongoing development of VX 509 and VX 787. These represent a flurry of data that will likely enhance analyst valuation of VRTX projected growth over the next few years, and likely push the stock higher in price.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
VRTX
127.81-5.39(-4.05%)3:51 PMEDT